Israel - English - Ministry of Health

teva israel ltd - benzylpenicillin sodium - powder for solution for injection - benzylpenicillin sodium 5 miu/vial - benzylpenicillin - benzylpenicillin - infections due to penicillin sensitive organisms.

Israel - English - Ministry of Health

teva israel ltd - benzylpenicillin sodium - powder for solution for injection - benzylpenicillin sodium 10 mu/vial - benzylpenicillin - benzylpenicillin - infections due to penicillin - sensitive microorganisms.

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v 500 mg - penicillin v potassium tablets, usp and penicillin v potassium for oral solution, usp, are indicated in the treatment of mild to moderately severe infections due to penicillin g- sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericarditis, meningitis, and arthritis should not be treated with penicillin v during the acute stage. indicated surgical procedures should be performed. the following infections will usually respond to adequate dosage of penicillin v: streptococcal infections (without bacteremia): mild-to-moderate infections of the upper respiratory tract, scarlet fever and mild erysipelas. note: streptococci in groups a, c, g, h, l, and m are very sensitive to penicillin. other groups, including group d (enterococcus) are resistant. pneumococcal infections : mild to moderately severe infections of the respiratory tract. staphylococcal infect

United States - English - NLM (National Library of Medicine)

blenheim pharmacal, inc. - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v 500 mg - penicillin v potassium tablets are indicated in the treatment of mild to moderately severe infections due to penicillin g-sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericarditis, meningitis, and arthritis should not be treated with penicillin v during the acute stage. indicated surgical procedures should be performed. the following infections will usually respond to adequate dosage of penicillin v. mild-to-moderate infections of the upper respiratory tract, scarlet fever, and mild erysipelas. note: streptococci in groups a, c, g, h, l, and m are very sensitive to penicillin. other groups, including group d (enterococcus), are resistant. mild to moderately severe infections of the respiratory tract. mild infections of the skin and soft tissues. note: reports indicate an increasing number of strains of staphylococci resistant to penicillin g, emphasizing the need for culture an

United States - English - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v 500 mg - penicillin v potassium tablets are indicated in the treatment of mild to moderately severe infections due to penicillin g-sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericarditis, meningitis, and arthritis should not be treated with penicillin v during the acute stage. indicated surgical procedures should be performed. the following infections will usually respond to adequate dosage of penicillin v. mild-to-moderate infections of the upper respiratory tract, scarlet fever, and mild erysipelas. note: streptococci in groups a, c, g, h, l, and m are very sensitive to penicillin. other groups, including group d (enterococcus), are resistant. mild to moderately severe infections of the respiratory tract. mild infections of the skin and soft tissues. note: reports indicate an increasing number of strains of staphylococci resistant to penicillin g, emphasizing the need for culture an

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v 500 mg - penicillin v potassium tablets are indicated in the treatment of mild to moderately severe infections due to penicillin g-sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericarditis, meningitis, and arthritis should not be treated with penicillin v during the acute stage. indicated surgical procedures should be performed. the following infections will usually respond to adequate dosage of penicillin v. mild-to-moderate infections of the upper respiratory tract, scarlet fever, and mild erysipelas. note: streptococci in groups a, c, g, h, l, and m are very sensitive to penicillin. other groups, including group d (enterococcus), are resistant. mild to moderately severe infections of the respiratory tract. mild infections of the skin and soft tissues. note: reports indicate an increasing number of strains of staphylococci resistant to penicillin g, emphasizing the need for culture an

United States - English - NLM (National Library of Medicine)

redpharm drug, inc. - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v 500 mg - penicillin v potassium tablets are indicated in the treatment of mild to moderately severe infections due to penicillin g-sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericarditis, meningitis, and arthritis should not be treated with penicillin v during the acute stage. indicated surgical procedures should be performed. the following infections will usually respond to adequate dosage of penicillin v. streptococcal infections (without bacteremia) mild-to-moderate infections of the upper respiratory tract, scarlet fever, and mild erysipelas. note: streptococci in groups a, c, g, h, l, and m are very sensitive to penicillin. other groups, including group d (enterococcus), are resistant. pneumococcal infections mild to moderately severe infections of the respiratory tract. staphylococcal infections – penicillin g-sensitive mild infections of the skin and soft tissues. note: reports

United States - English - NLM (National Library of Medicine)

sandoz inc - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v 250 mg - penicillin v potassium tablets are indicated in the treatment of mild to moderately severe infections due to penicillin g-sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericarditis, meningitis, and arthritis should not be treated with penicillin v during the acute stage. indicated surgical procedures should be performed. the following infections will usually respond to adequate dosage of penicillin v. mild-to-moderate infections of the upper respiratory tract, scarlet fever, and mild erysipelas. note: streptococci in groups a, c, g, h, l, and m are very sensitive to penicillin. other groups, including group d (enterococcus), are resistant. mild to moderately severe infections of the respiratory tract. mild infections of the skin and soft tissues. note: reports indicate an increasing number of strains of staphylococci resistant to penicillin g, emphasizing the need for culture an

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v 250 mg - penicillin v potassium tablets are indicated in the treatment of mild to moderately severe infections due to penicillin g-sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericarditis, meningitis, and arthritis should not be treated with penicillin v during the acute stage. indicated surgical procedures should be performed. the following infections will usually respond to adequate dosage of penicillin v. mild-to-moderate infections of the upper respiratory tract, scarlet fever, and mild erysipelas. note: streptococci in groups a, c, g, h, l, and m are very sensitive to penicillin. other groups, including group d (enterococcus), are resistant. mild to moderately severe infections of the respiratory tract. mild infections of the skin and soft tissues. note: reports indicate an increasing number of strains of staphylococci resistant to penicillin g, emphasizing the need for culture an

United States - English - NLM (National Library of Medicine)

sandoz inc - penicillin g sodium (unii: ys5ly7jf4n) (penicillin g - unii:q42t66vg0c) - penicillin g 5000000 [usp'u] - penicillin g sodium for injection, usp is indicated in the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below. appropriate culture and susceptibility tests should be done before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to penicillin g. therapy with penicillin g sodium for injection, usp may be initiated before results of such tests are known when there is reason to believe the infection may involve any of the organisms listed below, however, once these results become available, appropriate therapy should be continued. septicemia, empyema, pneumonia, pericarditis, endocarditis, meningitis streptococcus pyogenes (group a β-hemolytic streptococcus), other β-hemolytic streptococci including groups c, h, g, l and m, streptococcus pneumoniae and staphylococcus species (non- penicillinase producing strains) anthrax bacillus anthracis actinomycosis (cervico- facial disease a